Literature DB >> 15585333

The frequency of CCR5Delta32 and CCR2-64I in southern Iranian normal population.

Marjan Gharagozloo1, Mehrnoosh Doroudchi, Shirin Farjadian, Abdul Mohammad Pezeshki, Abbas Ghaderi.   

Abstract

Host genetic control of HIV infection involves certain polymorphisms of some chemokine receptor genes that are associated with susceptibility and progression of HIV-1 infection. Recent data suggest that two important polymorphisms in CCR2 and CCR5 chemokine receptors, CCR5Delta32 and CCR2-64I, prevent HIV transmission and delay disease progression. In this study allele and haplotype frequencies of the CCR5Delta32 and CCR2-64I mutations were determined in southern Iranian normal population using PCR and PCR restriction fragment length polymorphism (PCR-RFLP) assays. Allele frequencies and the fit to the Hardy-Weinberg equilibrium (HWE) were evaluated by Arlequin population genetic software. Frequencies of CCR5Delta32 and CCR2-64I alleles were 0.0146 and 0.1221, respectively. Moreover, higher and lower haplotype frequencies in 341 normal individuals were CCR2/CCR5 (0.8636) and CCR5/CCR2-64I (0.1217), respectively. Only one case with CCR5Delta32/CCR2-64I haplotype was found among the studied normal population. This data is the first finding on the frequencies of CCR5Delta32 and CCR2-64I alleles in Iranian population. Results of the present study suggest that low frequency of CCR5Delta32 allele may be related to higher genetic susceptibility to the HIV-1 infection in Iranians. Results also suggest that the CCR2-64I mutation is sufficiently common in Iranians and may be associated with slower HIV infection progression in Iran.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15585333     DOI: 10.1016/j.imlet.2004.09.007

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  10 in total

1.  The Consequence of a Founder Effect: CCR5-∆32, CCR2-64I and SDF1-3'A Polymorphism in Vlach Gypsy Population in Hungary.

Authors:  Emese Juhász; Judit Béres; Szilvia Kanizsai; Károly Nagy
Journal:  Pathol Oncol Res       Date:  2011-06-11       Impact factor: 3.201

2.  Impact of CCR2 and SDF1 polymorphisms on disease progression in HIV-infected subjects in Thailand.

Authors:  Palanee Ammaranond; Sayompoo Sanguansitthianan; Poonlaph Phaengchomduan; Chanachai Sae-Lee; Sirimarn Mardkhumchan
Journal:  J Clin Lab Anal       Date:  2013-01       Impact factor: 2.352

Review 3.  CCR2-V64I genetic polymorphism: a possible involvement in HER2+ breast cancer.

Authors:  Bruna Karina Banin-Hirata; Roberta Losi-Guembarovski; Julie Massayo Maeda Oda; Carlos Eduardo Coral de Oliveira; Clodoaldo Zago Campos; Tânia Longo Mazzuco; Sueli Donizete Borelli; Jesus Roberto Ceribelli; Maria Angelica Ehara Watanabe
Journal:  Clin Exp Med       Date:  2015-02-26       Impact factor: 3.984

Review 4.  Coincident natural selection of CCR5Delta32 and C282Y in Europe: to be or not to be?

Authors:  Marjan Gharagozloo; Abbas Ghaderi
Journal:  J Genet       Date:  2005-04       Impact factor: 1.508

5.  Distribution of the mutated delta 32 allele of CCR5 co-receptor gene in Iranian population.

Authors:  Hamzeh Rahimi; Mohammad M Farajollahi; Arshad Hosseini
Journal:  Med J Islam Repub Iran       Date:  2014-11-29

Review 6.  The frequency of CCR5 promoter polymorphisms and CCR5 Δ 32 mutation in Iranian populations.

Authors:  Mohammad Zare-Bidaki; Masoud Karimi-Googheri; Gholamhossein Hassanshahi; Nahid Zainodini; Mohammad Kazemi Arababadi
Journal:  Iran J Basic Med Sci       Date:  2015-04       Impact factor: 2.699

7.  Polymorphisms in CCR5Δ32 and Risk of HIV-1 Infection in the Southeast of Caspian Sea, Iran.

Authors:  Zahra Heydarifard; Alijan Tabarraei; Abdolvahab Moradi
Journal:  Dis Markers       Date:  2017-10-25       Impact factor: 3.434

8.  Prevalence of CCR5delta32 in Northeastern Iran.

Authors:  Amir Tajbakhsh; Mostafa Fazeli; Mehdi Rezaee; Faezeh Ghasemi; Mastoureh Momen Heravi; Aida Gholoobi; Zahra Meshkat
Journal:  BMC Med Genet       Date:  2019-11-15       Impact factor: 2.103

9.  CCR2-64I and CCR5Delta32 Polymorphisms in Korean Patients with Myasthenia Gravis.

Authors:  Hyun Sook Kim; Dae-Seong Kim; Eun Young Lee; Il-Nam Sunwoo; Young-Chul Choi
Journal:  J Clin Neurol       Date:  2007-09-20       Impact factor: 3.077

10.  Ccr2-64i and Ccr5 Δ32 Polymorphisms in Patients with Late-Onset Alzheimer's disease; A Study from Iran (Ccr2-64i And Ccr5 Δ32 Polymorphisms in Alzheimer's disease).

Authors:  Hamid Reza Khorram Khorshid; Mehdi Manoochehri; Leila Nasehi; Mina Ohadi; Mehdi Rahgozar; Koorosh Kamali
Journal:  Iran J Basic Med Sci       Date:  2012-07       Impact factor: 2.699

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.